As a board or panel member you will use your expertise and experience to help MRC invest in high-quality and impactful research, innovation and training as well as providing input into our strategy, including through interactions with other boards and panels and MRC’s advisory structures.
As it is not possible for individuals to provide in-depth expertise across all specialities, members will work collectively through open and objective discussions to provide advice across the board or panel remit, sharing responsibility for judgments and recommendations.
DPFS is MRC’s primary mechanism for supporting translational research. The DPFS Panel is responsible for supporting academic-led projects to progress fundamental and clinical research findings towards clinical use, wider health application, and commercialisation. DPFS supports a broad spectrum of activities from the development of novel therapies and interventions, devices, and diagnostics through to early-phase clinical studies. Projects are goal-orientated, and milestone monitored with clearly defined outcomes and downstream development plans.
The DPFS Panel also reviews and makes funding recommendations for the Developmental Pathway Gap Fund. The fund supports smaller scale funding to generate critical data that builds confidence in developing a new or repurposed medicine, medical device, diagnostic test, or other medical intervention.
For further information refer to the remit of the DPFS and Gap Fund.
We have up to eight vacancies for applicants with academic or industry translational expertise in at least one of the following areas:
- advanced therapies development and manufacturing
- regenerative medicine
- artificial intelligence and digital health, with experience of robotics or device development
- medical imaging technology development
- infectious disease immunobiology, to inform development of vaccines, therapies and diagnostic approaches
- ophthalmological translational research, for example imaging or regenerative medicine approaches
- surgery, for example development of surgical technologies
- autoimmunity or endocrinology
- musculoskeletal medicine
- clinical oncology
- clinical neurology
- statistics for clinical and pre-clinical research, particularly test evaluation
We particularly welcome applications from clinically active researchers, researchers based in industry and those with knowledge of the relevant investment landscape. Given the breadth of DPFS and Gap Fund applications, panel members are required to help cover areas outside of their primary expertise.
Applicants from, or with a connection to, University College London are unlikely to be suitable, due to the existing panel membership balance and high potential for conflicts of interest in these areas.
